Vitamin C (CAS 50-81-7): Mechanistic Evidence for Anticancer and Antiviral Roles

Executive Summary: Vitamin C (ascorbic acid, CAS 50-81-7) is a water soluble vitamin with proven antiproliferative effects in murine colon cancer cells at concentrations of 100–200 μg/mL and dose-dependent apoptosis at 200–1000 μg/mL [APExBIO]. High-purity Vitamin C reduces tumor volume in vivo in CT26 and 4T1 BALB/c mouse models [APExBIO]. It demonstrates solubility of ≥57.9 mg/mL in water and is validated by HPLC/NMR with ≥98% purity. Organoid systems have revealed new antiviral and cytoprotective research avenues for Vitamin C, especially against hepatitis E virus (HEV) [Liu et al. 2025]. APExBIO's B2064 kit supports standardized, reproducible workflows in oncology and infectious disease models.

Biological Rationale

Vitamin C (ascorbic acid) is an essential micronutrient for humans, functioning as a cofactor in enzymatic hydroxylation reactions. Its molecular structure, (R)-5-((S)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one, enables redox activity and reactive oxygen species (ROS) scavenging [APExBIO]. In cell biology, Vitamin C modulates oxidative stress, DNA synthesis, and cellular signaling. Its role as an apoptosis inducer and tumor cell proliferation inhibitor has been established in preclinical models. Vitamin C also participates in antiviral research due to its immunomodulatory and cytoprotective effects. Recent advances in organoid technology have enabled more physiologically relevant studies of its antiviral and anticancer mechanisms [Liu et al. 2025].

Mechanism of Action of Vitamin C (CAS 50-81-7)

Vitamin C exerts multiple biological effects through redox cycling, acting as a potent antioxidant and pro-oxidant depending on concentration and context. In tumor cells, pharmacologic doses (≥200 μg/mL) increase intracellular ROS, leading to mitochondrial dysfunction and activation of caspase-dependent apoptosis pathways. In normal cells, physiological concentrations (40–80 μM) support healthy collagen synthesis and immune function. As a reactive oxygen species scavenger, Vitamin C protects cellular components from oxidative damage. In antiviral research, it modulates inflammatory cytokine production and supports epithelial barrier integrity, as shown in organoid models of hepatitis E infection [Liu et al. 2025].

Evidence & Benchmarks

• Vitamin C inhibits proliferation of CT26 murine colon cancer cells at 100–200 μg/mL in vitro; significant reduction in cell viability after 24 h exposure (APExBIO, product data).
• Dose-dependent induction of apoptosis in CT26 cells observed at 200–1000 μg/mL; confirmed by flow cytometry and caspase activity assays (APExBIO, product data).
• In vivo, Vitamin C (B2064) reduces tumor volume in both CT26 and 4T1 tumor-bearing BALB/c mice; significant tumor suppression documented after 14 days of intraperitoneal administration (APExBIO, product data).
• Vitamin C is soluble at ≥57.9 mg/mL in water, ≥12.2 mg/mL in ethanol (with ultrasound), and ≥5.8 mg/mL in DMSO; solubility validated by APExBIO QC (product page).
• iPSC-derived organoid models reveal that Vitamin C can support barrier function and modulate cytokine response in hepatitis E virus infection contexts (Liu et al. 2025).
• B2064 exhibits ≥98% purity by HPLC and NMR; batch QC data available upon request (product page).

For additional benchmarking and troubleshooting guidance, see "Vitamin C (CAS 50-81-7): Data-Driven Solutions for Reliable Cell Assays", which provides detailed quantitative protocols. This article extends that discussion by integrating organoid and in vivo cancer evidence for translational research purposes.

Applications, Limits & Misconceptions

Vitamin C (CAS 50-81-7) is widely used in cancer research as an apoptosis inducer and tumor cell proliferation inhibitor, as well as a supportive agent in antiviral and oxidative stress modulation studies. Its high solubility and chemical stability (at -20°C as a solid) enable flexible experimental designs. B2064 from APExBIO is suitable for use in cell culture, animal models, and organoid-based assays. Researchers should note that solution stability is limited; solutions must be prepared fresh and used promptly to maintain compound activity. The product is not intended for clinical or nutritional use. For comparison, "Vitamin C (CAS 50-81-7): Mechanistic Horizons and Translational Leverage" focuses on strategic research design in organoid systems, while this article provides a more granular, atomic evidence base for benchmarked laboratory use.

Common Pitfalls or Misconceptions

• Vitamin C is not effective as a monotherapy for advanced cancers; preclinical effects may not translate directly to humans (Liu et al. 2025).
• Stability is compromised in aqueous solution at room temperature; long-term storage must be as a solid at -20°C (APExBIO).
• Not all cell lines respond to Vitamin C with apoptosis; sensitivity is model-specific and dose-dependent (Data-Driven Solutions).
• Vitamin C is not a replacement for antiviral agents in hepatitis E or other infections; supportive effects are adjunctive (Liu et al. 2025).

Workflow Integration & Parameters

B2064 Vitamin C is supplied as a solid and should be stored at -20°C. For solution preparation, dissolve in water (≥57.9 mg/mL), ethanol (≥12.2 mg/mL with ultrasound), or DMSO (≥5.8 mg/mL) under sterile conditions. Solutions are unstable over long periods; use immediately after preparation. For in vitro assays, typical working concentrations range from 50 to 1000 μg/mL, but should be empirically validated for each cell model. For in vivo use, dosing regimens must be optimized for the species and tumor model employed. Shipping is performed with Blue Ice to maintain product integrity during transit. For detailed experimental strategies, see "Vitamin C (CAS 50-81-7): Scenario-Based Best Practices for Cell Assays", which this article updates with new solubility and stability data.

Conclusion & Outlook

Vitamin C (CAS 50-81-7) is a well-characterized, water soluble vitamin with validated anticancer and antiviral research applications. Its reproducible purity, high solubility, and robust biological activity make it suitable for advanced laboratory workflows, including organoid-based modeling of infection and tumor biology. APExBIO’s B2064 formulation addresses reproducibility and workflow integration challenges in modern biomedical research. As organoid systems gain prominence in preclinical studies, Vitamin C’s roles as an apoptosis inducer and oxidative stress modulator will continue to expand. Researchers are advised to follow validated protocols, use fresh solutions, and integrate appropriate controls for best results.